Literature DB >> 32199827

National Outcomes of Surgical Embolectomy for Acute Pulmonary Embolism.

Edward D Percy1, Rohan Shah2, Sameer Hirji2, Richard J Tartarini3, Farhang Yazdchi2, Morgan Harloff2, Tsuyoshi Kaneko2, Marc P Pelletier4.   

Abstract

BACKGROUND: Guidelines outlining the role of surgical embolectomy for acute pulmonary embolism remain consensus based; however, recent outcomes have improved compared with traditional experiences. This study examined contemporary outcomes of patients treated for acute pulmonary embolism on a nationwide scale.
METHODS: Patients undergoing systemic thrombolysis, catheter-directed therapy, and surgical embolectomy for acute pulmonary embolism from 2010 to 2014 in the National Inpatient Sample were included.
RESULTS: The study included 58,974 patients with acute pulmonary embolism; of these, 33,553 were treated with systemic thrombolysis, 22,336 with catheter-directed therapy, and 3085 underwent surgical embolectomy. Thrombolysis was the most common, with a substantial increase after 2012, while surgical volumes remained stable. Patients in the surgical group, compared with systemic thrombolysis and catheter-directed therapy, had more saddle emboli (22% vs 10% vs 10%) and were more frequently at severe risk of death (56% vs 42% vs 26%; both P < .01). Surgical embolectomy patients had higher in-hospital mortality (20% vs 16% vs 7%), stroke (7% vs 6% vs 3%), and blood transfusion (32% vs 16% vs 10%; all P < .01). Rates of major bleeding and intracranial hemorrhage were highest in the systemic thrombolysis group. Among surgical patients, age older than 60 years, atrial fibrillation and nonsaddle embolus were associated with increased odds of mortality.
CONCLUSIONS: In this contemporary, real-world study, mortality occurred in 19.8% of patients undergoing surgical embolectomy for acute pulmonary embolism. This represents a significant improvement compared with traditional outcomes and supports the role of surgery in the multidisciplinary treatment of this high-risk condition.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Year:  2020        PMID: 32199827     DOI: 10.1016/j.athoracsur.2020.02.024

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  [Thrombus in all four heart chambers in a 67-year-old female patient with pulmonary artery embolism and open foramen ovale].

Authors:  O Kherbouche; W Ehrhardt; H Schweneker; R R Plentz; L P Graf
Journal:  Internist (Berl)       Date:  2021-11-26       Impact factor: 0.743

2.  Treatment strategies for thromboembolism-in-transit with pulmonary embolism.

Authors:  Hiroki Sakai; Takayuki Uchida; Takashi Matsumoto
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-07-09

3.  Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients.

Authors:  Arkadiusz Pietrasik; Aleksandra Gąsecka; Łukasz Szarpak; Michał Pruc; Tomasz Kopiec; Szymon Darocha; Marta Banaszkiewicz; Maciej Niewada; Marcin Grabowski; Marcin Kurzyna
Journal:  Front Cardiovasc Med       Date:  2022-06-16

4.  Efficacy and Safety of Veno-Arterial Extracorporeal Membrane Oxygenation in the Treatment of High-Risk Pulmonary Embolism: A Retrospective Cohort Study.

Authors:  Hao-Yu Tsai; Yu-Tang Wang; Wei-Chieh Lee; Hsu-Ting Yen; Chien-Ming Lo; Chia-Chen Wu; Kwan-Ru Huang; Yin-Chia Chen; Jiunn-Jye Sheu; Yen-Yu Chen
Journal:  Front Cardiovasc Med       Date:  2022-03-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.